Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy: an analysis of the DiaRegis registry
Background: Type-2 diabetes mellitus has a major impact on health related quality of life (HRQoL). We aimed to identify patient and treatment related variables having a major impact. Methods: DiaRegis is a prospective diabetes registry. The EQ-5D was used to describe differences in HRQoL at baseline...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 March 2013
|
| In: |
Cardiovascular diabetology
Year: 2013, Jahrgang: 12, Pages: 1-8 |
| ISSN: | 1475-2840 |
| DOI: | 10.1186/1475-2840-12-47 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1475-2840-12-47
|
| Verfasserangaben: | Jürgen Wasem, Peter Bramlage, Anselm K. Gitt, Christiane Binz, Michael Krekler, Evelin Deeg, Diethelm Tschöpe, for the DiaRegis Study Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1772152722 | ||
| 003 | DE-627 | ||
| 005 | 20230427160110.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210930s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1475-2840-12-47 |2 doi | |
| 035 | |a (DE-627)1772152722 | ||
| 035 | |a (DE-599)KXP1772152722 | ||
| 035 | |a (OCoLC)1341421652 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wasem, Jürgen |d 1959- |e VerfasserIn |0 (DE-588)110790677 |0 (DE-627)53798481X |0 (DE-576)16406219X |4 aut | |
| 245 | 1 | 0 | |a Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy |b an analysis of the DiaRegis registry |c Jürgen Wasem, Peter Bramlage, Anselm K. Gitt, Christiane Binz, Michael Krekler, Evelin Deeg, Diethelm Tschöpe, for the DiaRegis Study Group |
| 264 | 1 | |c 20 March 2013 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.09.2021 | ||
| 520 | |a Background: Type-2 diabetes mellitus has a major impact on health related quality of life (HRQoL). We aimed to identify patient and treatment related variables having a major impact. Methods: DiaRegis is a prospective diabetes registry. The EQ-5D was used to describe differences in HRQoL at baseline. Odds ratios (OR) with 95% confidence intervals (CI) were determined from univariable regression analysis. For the identification of independent predictors of a low score on the EQ-5D, multivariable unconditional logistic regression analysis was performed. Results: A total of 2,760 patients were available for the present analysis (46.7% female, median age 66.2 years). Patients had considerable co-morbidity (18.3% coronary artery disease, 10.6% heart failure, 5.9% PAD and 5.0% stroke/TIA). Baseline HbA1c was 7.4%, fasting- and postprandial plasma glucose 139 mg/dl and 183 mg/dl. The median EQ-5D was 0.9 (interquartile range [IQR] 0.8–1.0). Independent predictors for a low EQ-5D were age > 66 years (OR 1.49; 95%CI 1.08–2.06), female gender (2.11; 1.55–2.86), hypertension (1.73; 1.03–2.93), peripheral neuropathy (1.62; 0.93–2.84) and clinically relevant depression (11.01; 3.97–30.50). There was no influence of dysglycaemia on the EQ-5D score. Conclusion: The present study suggests, that co-morbidity but not average glycaemic control reduces health related quality of life in type 2 diabetes mellitus. | ||
| 650 | 4 | |a Glipizide | |
| 650 | 4 | |a Glycaemic Control | |
| 650 | 4 | |a Metformin | |
| 650 | 4 | |a Minimal Important Difference | |
| 650 | 4 | |a Peripheral Artery Disease | |
| 700 | 1 | |a Bramlage, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gitt, Anselm Kai |d 1964- |e VerfasserIn |0 (DE-588)124753132 |0 (DE-627)365720836 |0 (DE-576)294482792 |4 aut | |
| 700 | 1 | |a Binz, Christiane |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krekler, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Deeg, Evelin |e VerfasserIn |0 (DE-588)1162153725 |0 (DE-627)1025590236 |0 (DE-576)507031520 |4 aut | |
| 700 | 1 | |a Tschöpe, Diethelm |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiovascular diabetology |d London : BioMed Central, 2002 |g 12(2013), Artikel-ID 47, Seite 1-8 |h Online-Ressource |w (DE-627)356593665 |w (DE-600)2093769-6 |w (DE-576)107015390 |x 1475-2840 |7 nnas |a Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy an analysis of the DiaRegis registry |
| 773 | 1 | 8 | |g volume:12 |g year:2013 |g elocationid:47 |g pages:1-8 |g extent:8 |a Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy an analysis of the DiaRegis registry |
| 856 | 4 | 0 | |u https://doi.org/10.1186/1475-2840-12-47 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210930 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1162153725 |a Deeg, Evelin |m 1162153725:Deeg, Evelin |d 910000 |d 913000 |e 910000PD1162153725 |e 913000PD1162153725 |k 0/910000/ |k 1/910000/913000/ |p 6 | ||
| 998 | |g 124753132 |a Gitt, Anselm Kai |m 124753132:Gitt, Anselm Kai |d 50000 |e 50000PG124753132 |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1772152722 |e 3982614465 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Jürgen Wasem, Peter Bramlage, Anselm K. Gitt, Christiane Binz, Michael Krekler, Evelin Deeg, Diethelm Tschöpe, for the DiaRegis Study Group"]},"origin":[{"dateIssuedDisp":"20 March 2013","dateIssuedKey":"2013"}],"id":{"eki":["1772152722"],"doi":["10.1186/1475-2840-12-47"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"id":{"zdb":["2093769-6"],"eki":["356593665"],"issn":["1475-2840"]},"origin":[{"publisher":"BioMed Central","dateIssuedKey":"2002","dateIssuedDisp":"2002-","publisherPlace":"London"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Cardiovascular diabetology","title":"Cardiovascular diabetology"}],"language":["eng"],"recId":"356593665","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 25.05.2020"],"disp":"Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy an analysis of the DiaRegis registryCardiovascular diabetology","part":{"pages":"1-8","year":"2013","extent":"8","text":"12(2013), Artikel-ID 47, Seite 1-8","volume":"12"},"pubHistory":["1.2002 -"]}],"person":[{"roleDisplay":"VerfasserIn","display":"Wasem, Jürgen","role":"aut","family":"Wasem","given":"Jürgen"},{"given":"Peter","family":"Bramlage","role":"aut","roleDisplay":"VerfasserIn","display":"Bramlage, Peter"},{"given":"Anselm Kai","family":"Gitt","role":"aut","display":"Gitt, Anselm Kai","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Binz, Christiane","given":"Christiane","family":"Binz"},{"roleDisplay":"VerfasserIn","display":"Krekler, Michael","role":"aut","family":"Krekler","given":"Michael"},{"given":"Evelin","family":"Deeg","role":"aut","display":"Deeg, Evelin","roleDisplay":"VerfasserIn"},{"given":"Diethelm","family":"Tschöpe","role":"aut","roleDisplay":"VerfasserIn","display":"Tschöpe, Diethelm"}],"title":[{"subtitle":"an analysis of the DiaRegis registry","title":"Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy","title_sort":"Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy"}],"note":["Gesehen am 30.09.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1772152722"} | ||
| SRT | |a WASEMJUERGCOMORBIDIT2020 | ||